Somatic gene therapy into hematopoietic cells: Current status and future implications

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Retroviral-mediated gene transfer is a powerful tool for introducing and expressing single genes into hematopoietic cells. There has clearly been a tremendous amount of progress in the development of retroviral gene transfer technology over the past 7 years. This is evidenced by improvements in transduction efficiency and expression in animals and its selected use currently in human trials. Critical experiments that must yet be performed relate to the in vitro identification, transduction, and expansion of pluripotent hematopoietic stem cells in vitro as well as the development of retroviral vectors that maximize in vivo expression in the desired target cells.

Original languageEnglish
Pages (from-to)155-168
Number of pages14
JournalClinics in Perinatology
Volume20
Issue number1
StatePublished - 1993

Fingerprint

Genetic Therapy
Genes
Technology Transfer
Pluripotent Stem Cells
Hematopoietic Stem Cells
In Vitro Techniques

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Somatic gene therapy into hematopoietic cells : Current status and future implications. / Clapp, D.

In: Clinics in Perinatology, Vol. 20, No. 1, 1993, p. 155-168.

Research output: Contribution to journalArticle

@article{139a3f0eac6846198ff37db8e119f92c,
title = "Somatic gene therapy into hematopoietic cells: Current status and future implications",
abstract = "Retroviral-mediated gene transfer is a powerful tool for introducing and expressing single genes into hematopoietic cells. There has clearly been a tremendous amount of progress in the development of retroviral gene transfer technology over the past 7 years. This is evidenced by improvements in transduction efficiency and expression in animals and its selected use currently in human trials. Critical experiments that must yet be performed relate to the in vitro identification, transduction, and expansion of pluripotent hematopoietic stem cells in vitro as well as the development of retroviral vectors that maximize in vivo expression in the desired target cells.",
author = "D. Clapp",
year = "1993",
language = "English",
volume = "20",
pages = "155--168",
journal = "Clinics in Perinatology",
issn = "0095-5108",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Somatic gene therapy into hematopoietic cells

T2 - Current status and future implications

AU - Clapp, D.

PY - 1993

Y1 - 1993

N2 - Retroviral-mediated gene transfer is a powerful tool for introducing and expressing single genes into hematopoietic cells. There has clearly been a tremendous amount of progress in the development of retroviral gene transfer technology over the past 7 years. This is evidenced by improvements in transduction efficiency and expression in animals and its selected use currently in human trials. Critical experiments that must yet be performed relate to the in vitro identification, transduction, and expansion of pluripotent hematopoietic stem cells in vitro as well as the development of retroviral vectors that maximize in vivo expression in the desired target cells.

AB - Retroviral-mediated gene transfer is a powerful tool for introducing and expressing single genes into hematopoietic cells. There has clearly been a tremendous amount of progress in the development of retroviral gene transfer technology over the past 7 years. This is evidenced by improvements in transduction efficiency and expression in animals and its selected use currently in human trials. Critical experiments that must yet be performed relate to the in vitro identification, transduction, and expansion of pluripotent hematopoietic stem cells in vitro as well as the development of retroviral vectors that maximize in vivo expression in the desired target cells.

UR - http://www.scopus.com/inward/record.url?scp=0027405944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027405944&partnerID=8YFLogxK

M3 - Article

C2 - 8458163

AN - SCOPUS:0027405944

VL - 20

SP - 155

EP - 168

JO - Clinics in Perinatology

JF - Clinics in Perinatology

SN - 0095-5108

IS - 1

ER -